The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

This section has no associated Explanatory Memorandum

137.  In regulation 175 (amendment of regulation 210A (offences in relation to pharmacovigilance obligations under the Implementing Regulation))—U.K.

(a)in paragraph (2)—

(i)for “for” substitute “ after ”;

(ii)for “substitute “Schedule 12A”” substitute “ insert “and Schedule 12A” ”;

(b)in paragraph (3) for sub-paragraphs (a) and (b) substitute—

(a)in sub-paragraph (a), at the beginning insert “ in relation to a UKMA(NI), UKMA(UK), THR(NI) THR(UK) or Article 126a authorisation, ”;

(b)after sub-paragraph (a) insert—

(aa)in relation to a UKMA(GB) or THR(GB), fails to comply with any requirement or obligation contained in a provision of Schedule 12A listed in paragraph (2A); or.;

(c)in paragraph (4)—

(i)for “For paragraph (2) substitute” substitute “ After paragraph (2) insert ”;

(ii)the inserted paragraph (2) becomes inserted paragraph (2A);

(iii)omit the inserted paragraphs (3) and (4);

(d)after paragraph (4) insert—

(5) In paragraph (4), after “Implementing Regulation” insert “ , or of paragraph 26(8) or 29(1) of Schedule 12A, ”..

Commencement Information

I1Sch. 2 para. 137 in force at 31.12.2020 immediately before IP completion day, see reg. 1